Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB · Entity 5650 | Chief Accounting Officer | February 22, 2021 | February 24, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Report date February 22, 2021 · Filed February 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 88,474 |
Reported balance
After 2021-02-22 transaction · row 1
1 source rowRow 1 · 2021-02-22 · Sale · Disposed 3,842 · Balance 88,474 F1: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units F2: This sale price represents the weighted average sale price of the shares sold ranging from $39.00 to $39.36 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units
F2: This sale price represents the weighted average sale price of the shares sold ranging from $39.00 to $39.36 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2021 Filed Feb 24, 2021 20:21 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 3,842 | $39.20 | $150,606.40 |
DisclosureSEC source: 0001299130-21-000085 · certent-form4.xml · nonDerivative · entry 1 Schaefer Eric · CIK 0001813942 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,474 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $39.00 to $39.36 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:48 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 10,100 | $0.00 Strike: $46.37 | $0.00 |
DisclosureSEC source: 0001299130-21-000069 · certent-form4.xml · derivative · entry 2 Schaefer Eric · CIK 0001813942 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 Underlying: Common Stock · 10,100 shares Expires 2031-02-16 F3 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:48 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 5,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-21-000069 · certent-form4.xml · nonDerivative · entry 1 Schaefer Eric · CIK 0001813942 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,316 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 16 of each of 2022, 2023, 2024, and 2025, provided that the Reporting Person continues to serve through each vesting date. F2 · balance_after: Includes 7,267 shares acquired under the Issuer's Employee Stock Purchase Plan on September 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.